Nachrichten zur PHARMING GRP EO-,01 Aktie

Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH):...

^ Original-Research: Pharming Group NV - from First Berlin Equity Research GmbH 03.04.2025 / 17:08 CET/CEST Dissemination of a Research,…

Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH):...

^Original-Research: Pharming Group NV - from First Berlin Equity ResearchGmbH03.04.2025 / 17:08 CET/CESTDissemination of a Research, transmitted by EQS News…

Pharming Group announces the filing of its 2024 Annual Report and Form 20-F

Leiden, the Netherlands, April 3, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces the…

Pharming Group reports fourth quarter and full year 2024 financial results and provides business update

Leiden, the Netherlands, March 13, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) presents…

Pharming Group to participate in March investor conference

Leiden, the Netherlands, February 28, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in…

Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH):...

^ Original-Research: Pharming Group NV - from First Berlin Equity Research GmbH 29.10.2024 / 14:51 CET/CEST Dissemination of a Research,…

Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH):...

^Original-Research: Pharming Group NV - from First Berlin Equity ResearchGmbH29.10.2024 / 14:51 CET/CESTDissemination of a Research, transmitted by EQS News…

Pharming Group to report third quarter 2024 financial results on October 24

Leiden, the Netherlands, October 10, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary…

Pharming Group to participate in September investor conferences

Leiden, the Netherlands, September 4, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate…

Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH):...

^Original-Research: Pharming Group NV - from First Berlin Equity ResearchGmbH26.08.2024 / 15:55 CET/CESTDissemination of a Research, transmitted by EQS News…

Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH):...

^ Original-Research: Pharming Group NV - from First Berlin Equity Research GmbH 26.08.2024 / 15:55 CET/CEST Dissemination of a Research,…

Pharming Group reports second quarter and first half 2024 financial results and provides business update

Leiden, the Netherlands, August 1, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) presents its preliminary…

Pharming Group to report second quarter and first half 2024 financial results on August 1

Leiden, the Netherlands, July 18, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary…

Pharming Group N.V. 2024 Q1 - Results - Earnings Call Presentation

…

Pharming Group N.V. (PHAR) Q1 2024 Earnings Call Transcript

…

Pharming Group to report first quarter 2024 financial results on May 8

Leiden, the Netherlands, April 24, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary…

Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains?

Pharming Group (PHAR) saw its shares surge in the last session with trading volume being higher than average. The latest…

Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025

NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY…

Pharming Group announces the placement of €100 million convertible bonds due 2029

NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY…

Pharming Group announces the 2024 Annual General Meeting of Shareholders

Leiden, The Netherlands, April 4, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces…

Pharming Group announces the filing of its 2023 Annual Report and Form 20-F

Leiden, The Netherlands, April 4, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces…

Pharming Group N.V. (PHAR) Q4 2023 Earnings Call Transcript

…

Pharming Group N.V. 2023 Q4 - Results - Earnings Call Presentation

…

Pharming Group reports fourth quarter and full year 2023 financial results

Leiden, The Netherlands, March 14, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) presents…

Pharming Group to report fourth quarter and full year 2023 financial results on March 14

Leiden, The Netherlands, February 29, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary…

Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH):...

^ Original-Research: Pharming Group NV - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research…

Original-Research: Pharming (von First Berlin Equity Research GmbH): Buy

^ Original-Research: Pharming - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu…

dpa-AFX ProFeed